Barbara Alicia Jerechek is the Director of the Radiotherapy Unit at the European Oncology Centre in Milan and Professor of Radiation Oncology at the University of Milan. The doctor specializes in radiotherapy for all types of cancer and metastatic tumors.
Professor Jereczek received her medical degree from the University of Gdansk (Poland) in 1992. She completed advanced training in radiation oncology at the Warsaw Cancer Institute, the University of Milan, and the Beatson Cancer Centre at the University of Glasgow (UK). Since 1997, the doctor has been working as a radiotherapy specialist at the European Cancer Centre. Since 2015, she has been the head of the radiotherapy department at the clinic.
An appointment with Dr. Erechek to plan radiation therapy takes 30-50 minutes. The doctor reviews the patient's medical records and test results. She explains the diagnosis and talks about how further treatment will proceed. The doctor gives recommendations on how best to prepare for the course of procedures so that they are as comfortable as possible.
To get a consultation with Professor Erechek, leave a request on the Bookimed website. A coordinating doctor will contact you to agree on the date and time of the consultation.
Professor Barbara Alicia Ereczek is the author of 140 scientific publications.
Between 1999 and 2003, Professor Jereczek received 4 awards from the Medical University of Gdansk for scientific research in the field of oncology and radiotherapy.
Barbara Alicia Jerechek is the Director of the Radiotherapy Unit at the European Oncology Centre in Milan and Professor of Radiation Oncology at the University of Milan. The doctor specializes in radiotherapy for all types of cancer and metastatic tumors.
Professor Jereczek received her medical degree from the University of Gdansk (Poland) in 1992. She completed advanced training in radiation oncology at the Warsaw Cancer Institute, the University of Milan, and the Beatson Cancer Centre at the University of Glasgow (UK). Since 1997, the doctor has been working as a radiotherapy specialist at the European Cancer Centre. Since 2015, she has been the head of the radiotherapy department at the clinic.
An appointment with Dr. Erechek to plan radiation therapy takes 30-50 minutes. The doctor reviews the patient's medical records and test results. She explains the diagnosis and talks about how further treatment will proceed. The doctor gives recommendations on how best to prepare for the course of procedures so that they are as comfortable as possible.
To get a consultation with Professor Erechek, leave a request on the Bookimed website. A coordinating doctor will contact you to agree on the date and time of the consultation.
Professor Barbara Alicia Ereczek is the author of 140 scientific publications.
Between 1999 and 2003, Professor Jereczek received 4 awards from the Medical University of Gdansk for scientific research in the field of oncology and radiotherapy.
Professor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.
He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977.
In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa.
Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University.
Current Positions:
In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009).
Publications: santoro%a - Search Results - PubMed (nih.gov)
Read moreProfessor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.
He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977.
In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa.
Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University.
Current Positions:
In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009).
Publications: santoro%a - Search Results - PubMed (nih.gov)